The content is available as a PDF (789.8 KB).
. 2020 Nov 5:hpaa175. doi: 10.1093/ajh/hpaa175
ACE2 and SARS-CoV-2 – tissue or plasma, good or bad?
Ulrich O Wenzel
1,✉, Ulrich Kintscher
2
Ulrich O Wenzel
1
Department of Medicine, University Hospital Hamburg-Eppendorf, Hamburg
Find articles by Ulrich O Wenzel
Ulrich Kintscher
2
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pharmacology, Center for Cardiovascular Research, Berlin, Germany
Find articles by Ulrich Kintscher
1
Department of Medicine, University Hospital Hamburg-Eppendorf, Hamburg
2
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pharmacology, Center for Cardiovascular Research, Berlin, Germany
✉
Correspondence to: Ulrich Wenzel, III. Department of Medicine, University Hospital Hamburg-Eppendorf, Martinistr. 52; 20246 Hamburg, Germany, Phone: +4940741050062, Fax: +4940741055186, Mail: wenzel@uke.de
Received 2020 Oct 21.
© American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7665354 PMID: 33151267